HomeVM • CVE
add
Voyageur Pharmaceuticals Ltd
Previous close
$0.18
Day range
$0.18 - $0.18
Year range
$0.040 - $0.25
Market cap
28.11M CAD
Avg Volume
120.10K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 400.12K | 79.72% |
Net income | -458.51K | -62.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -399.73K | -79.99% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 169.07K | 2,927.20% |
Total assets | 2.60M | 20.09% |
Total liabilities | 2.15M | 195.16% |
Total equity | 449.96K | — |
Shares outstanding | 139.47M | — |
Price to book | ∞ | — |
Return on assets | -40.56% | — |
Return on capital | -134.16% | — |
Cash Flow
Net change in cash
| (CAD) | Nov 2024info | Y/Y change |
|---|---|---|
Net income | -458.51K | -62.40% |
Cash from operations | 81.14K | 76.74% |
Cash from investing | -35.32K | -6.37% |
Cash from financing | 116.71K | 1,033.71% |
Net change in cash | 162.53K | 79,966.01% |
Free cash flow | 420.88K | 361.01% |
About
Founded
2008
Headquarters
Website
